small volume accelerated chemoradiotherapy
Showing 51 - 75 of >10,000
Chemo Effect, Rectal Cancer Trial in Guangzhou (Radical total mesorectal excision, Salavge Adjuvant Chemoradiotherapy)
Recruiting
- Chemotherapy Effect
- Rectal Cancer
- Radical total mesorectal excision
- Salavge Adjuvant Chemoradiotherapy
-
Guangzhou, Guangdong, ChinaGastrointestinal Hospital, Sun Yat-sen University
Sep 12, 2023
Locally Advanced Nasopharyngeal Carcinoma Trial in Guangzhou (2 cycles induction chemo, 3 cycles induction chemo)
Recruiting
- Locally Advanced Nasopharyngeal Carcinoma
- 2 cycles induction chemotherapy
- 3 cycles induction chemotherapy
-
Guangzhou, Other (Non U.s.), ChinaFirst Affiliated Hospital, Sun Yat-Sen University
May 6, 2023
Esophageal Squamous Cell Carcinoma Trial in Nanjing (Carrelizumab, Paclitaxel injection, Cisplatin)
Enrolling by invitation
- Esophageal Squamous Cell Carcinoma
- Carrelizumab
- +3 more
-
Nanjing, ChinaThe First Affiliated Hospital of Nanjing Medical University
Sep 19, 2023
NSCLC (NSCLC) Trial in Worldwide (Atezolizumab, Tiragolumab, Durvalumab)
Recruiting
- Non-small Cell Lung Cancer (NSCLC)
- Atezolizumab
- +2 more
-
Tempe, Arizona
- +254 more
Aug 8, 2022
Ventilation, Lung Function, Anesthesia, General Trial in Geneva (General anesthesia for laryngotracheal surgery, Mechanical
Recruiting
- Ventilation
- +2 more
- General anesthesia for laryngotracheal surgery
- +2 more
-
Geneva, SwitzerlandGeneva University Hospitals
Sep 25, 2023
Limited Stage Small Cell Lung Cancer Trial in Shanghai (Pamiparib)
Recruiting
- Limited Stage Small Cell Lung Cancer
-
Shanghai, Shanghai, China
- +1 more
Jul 29, 2022
Esophageal Squamous Cell Carcinoma, Chemo Effect, Side Effect of Drug Trial in Nanjing (Consolidation chemo (4 courses),
Recruiting
- Esophageal Squamous Cell Carcinoma
- +2 more
- Consolidation chemotherapy (4 courses)
- Concurrent chemotherapy (2 courses)
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital of Nanjing Medical University
Mar 16, 2023
Cancer of Head and Neck, Mucositis Oral, Pharyngeal Mucositis Trial in Lake Success (Ketamine Topical)
Not yet recruiting
- Cancer of Head and Neck
- +2 more
- Ketamine Topical
-
Lake Success, New YorkCenter for Advanced Medicine
Nov 1, 2022
Novel Predictors of Premature Aging in COPD Patients
Not yet recruiting
- COPD
- SCINEXA score
- (no location specified)
Aug 25, 2023
Esophageal Cancer Trial (Hypofractionated radiotherapy)
Not yet recruiting
- Esophageal Cancer
- Hypofractionated radiotherapy
- (no location specified)
Jan 18, 2023
Retrospective Study Trial in Melsbroek
Completed
- Retrospective Study
-
Melsbroek, Vlaams-Brabant, BelgiumNationaal Multiple Sclerose Centrum Melsbroek
Jun 7, 2022
Schizophrenia, Schizoaffective Disorder Trial in Pittsburgh (sham stimulation, transcranial magnetic stimulation)
Not yet recruiting
- Schizophrenia
- Schizoaffective Disorder
- sham stimulation
- transcranial magnetic stimulation
-
Pittsburgh, PennsylvaniaUPMC Western Psychiatric Hospital/University of Pittsburgh
Aug 14, 2023
Limited Stage Small Cell Lung Cancer, Small Cell Lung Cancer Trial in Worldwide (Tarlatamab, Placebo)
Not yet recruiting
- Limited Stage Small Cell Lung Cancer
- Small Cell Lung Cancer
- Tarlatamab
- Placebo
-
Minneapolis, Minnesota
- +124 more
Oct 31, 2023
NSCLC Trial in Jinan (Anlotinib HCl capsule Combined With Concurrent Chemoradiotherapy)
Terminated
- Non-small Cell Lung Cancer
- Anlotinib hydrochloride capsule Combined With Concurrent Chemoradiotherapy
-
Jinan, Shandong, ChinaShandong Cancer Hospital
Feb 9, 2022
Corneal Epithelial Degeneration Trial in Cypress (TTHX1114(NM141) Ophthalmic Solution)
Recruiting
- Corneal Epithelial Degeneration
- TTHX1114(NM141) Ophthalmic Solution
-
Cypress, CaliforniaTrefoil Clinical Site #132
Mar 3, 2023
Treatment Resistant Depression Trial in Stanford (Active TBS-DLPFC, Sham TBS-DLPFC, Open label TBS-DLPFC)
Withdrawn
- Treatment Resistant Depression
- Active TBS-DLPFC
- +2 more
-
Stanford, CaliforniaDepartment of Psychiatry and Behavioral Sciences, Stanford Schoo
Dec 12, 2022
Breast Cancer Trial in Brussels, Dendermonde (Tomotherapy)
Completed
- Breast Cancer
- Tomotherapy
-
Brussels, Belgium
- +2 more
Jul 19, 2022
Treatment-resistant Depression Trial in Hangzhou (active iTBS, sham rTMS)
Recruiting
- Treatment-resistant Depression
- active iTBS
- sham rTMS
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital of Zhejiang University
Jan 12, 2023
Pancreatic Carcinoma Trial in Nanjing (Toripalimab, Gemcitabine, Nab paclitaxel)
Not yet recruiting
- Pancreatic Carcinoma
- Toripalimab
- +3 more
-
Nanjing, Jiangsu, ChinaThe Affiliated Nanjing Drum Tower Hospital of Nanjing University
Oct 6, 2023
Metastatic Non Small Cell Lung Cancer Trial in Worldwide (Lazertinib, Amivantamab Subcutaneous and Co-Formulated with
Recruiting
- Advanced or Metastatic Non-small Cell Lung Cancer
- Lazertinib
- +2 more
-
Duarte, California
- +208 more
Jan 31, 2023
NSCLC Stage III Trial (radiotherapy, Platinum-Based Drug, Immunotherapy)
Not yet recruiting
- Non-small Cell Lung Cancer Stage III
- radiotherapy
- +3 more
- (no location specified)
Sep 10, 2023
Esophageal Squamous Cell Carcinoma Trial in China (1% Lugol's iodine solution, 5% Lugol's iodine solution)
Not yet recruiting
- Esophageal Squamous Cell Carcinoma
- 1% Lugol's iodine solution
- 5% Lugol's iodine solution
-
Ankang, Shaanxi, China
- +5 more
Sep 25, 2023
Treatment Resistant Depression Trial in Stanford (Active TBS-DLPFC, TBS-DMPFC)
Not yet recruiting
- Treatment Resistant Depression
- Active TBS-DLPFC
- TBS-DMPFC
-
Stanford, CaliforniaStanford University
Sep 18, 2023
Liver Trial in Houston (Questionnaires)
Not yet recruiting
- Liver
- Questionnaires
-
Houston, TexasM D Anderson Cancer Center
May 26, 2023